MXCT
Income statement / Annual
Last year (2025), MaxCyte Inc's total revenue was $33.03 M,
a decrease of 14.50% from the previous year.
In 2025, MaxCyte Inc's net income was -$44.63 M.
See MaxCyte Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$33.03 M |
$38.63 M |
$41.29 M |
$44.26 M |
$33.89 M |
$26.17 M |
$21.62 M |
$16.67 M |
$13.99 M |
$12.27 M |
| Cost of Revenue |
$6.22 M
|
$7.10 M
|
$4.74 M
|
$5.10 M
|
$3.65 M
|
$2.77 M
|
$2.50 M
|
$1.84 M
|
$1.45 M
|
$1.31 M
|
| Gross Profit |
$26.80 M
|
$31.53 M
|
$36.55 M
|
$39.16 M
|
$30.25 M
|
$23.40 M
|
$19.12 M
|
$14.83 M
|
$12.53 M
|
$10.96 M
|
| Gross Profit Ratio |
0.81
|
0.82
|
0.89
|
0.88
|
0.89
|
0.89
|
0.88
|
0.89
|
0.9
|
0.89
|
| Research and Development Expenses |
$20.82 M
|
$22.23 M
|
$23.82 M
|
$19.51 M
|
$15.41 M
|
$17.73 M
|
$17.59 M
|
$11.24 M
|
$11.28 M
|
$4.70 M
|
| General & Administrative Expenses |
$28.12 M
|
$29.69 M
|
$30.07 M
|
$25.83 M
|
$18.68 M
|
$7.37 M
|
$5.56 M
|
$5.28 M
|
$4.52 M
|
$4.20 M
|
| Selling & Marketing Expenses |
$18.92 M
|
$26.66 M
|
$26.98 M
|
$18.65 M
|
$13.00 M
|
$8.33 M
|
$7.85 M
|
$6.72 M
|
$6.02 M
|
$4.78 M
|
| Selling, General & Administrative Expenses |
$47.04 M
|
$56.35 M
|
$57.04 M
|
$44.48 M
|
$31.68 M
|
$15.70 M
|
$13.41 M
|
$12.01 M
|
$10.54 M
|
$8.99 M
|
| Other Expenses |
$4.23 M
|
$4.14 M
|
$3.99 M
|
$2.53 M
|
$1.35 M
|
$1.03 M
|
$541.30 K
|
$0.00
|
$0.00
|
$15.70 K
|
| Operating Expenses |
$72.09 M
|
$82.72 M
|
$84.85 M
|
$66.52 M
|
$48.44 M
|
$34.46 M
|
$31.54 M
|
$23.25 M
|
$21.82 M
|
$13.69 M
|
| Cost And Expenses |
$78.31 M
|
$89.82 M
|
$89.59 M
|
$71.62 M
|
$52.08 M
|
$37.23 M
|
$34.04 M
|
$25.09 M
|
$23.28 M
|
$14.99 M
|
| Interest Income |
$7.27 M
|
$10.14 M
|
$10.38 M
|
$3.92 M
|
$150.80 K
|
$65.90 K
|
$206.10 K
|
$170.30 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$126.90 K
|
$1.04 M
|
$825.60 K
|
$681.10 K
|
$614.60 K
|
$625.30 K
|
$637.80 K
|
| Depreciation & Amortization |
$5.14 M
|
$4.79 M
|
$4.17 M
|
$2.70 M
|
$1.42 M
|
$1.05 M
|
$613.50 K
|
$344.00 K
|
$142.90 K
|
$105.70 K
|
| EBITDA |
-$39.49 M |
-$36.27 M |
-$33.75 M |
-$20.75 M |
-$16.61 M |
-$9.94 M |
-$11.60 M |
-$7.91 M |
-$9.15 M |
-$2.60 M |
| EBITDA Ratio |
-1.2
|
-0.94
|
-0.82
|
-0.47
|
-0.49
|
-0.38
|
-0.54
|
-0.47
|
-0.65
|
-0.21
|
| Operating Income Ratio |
-1.37
|
-1.33
|
-1.17
|
-0.62
|
-0.54
|
-0.42
|
-0.57
|
-0.51
|
-0.66
|
-0.22
|
| Total Other Income/Expenses Net |
$655.00 K
|
$10.14 M
|
$10.38 M
|
$3.79 M
|
-$893.60 K
|
-$759.70 K
|
-$475.00 K
|
-$444.30 K
|
-$625.30 K
|
-$622.10 K
|
| Income Before Tax |
-$44.63 M
|
-$41.06 M
|
-$37.92 M
|
-$23.57 M
|
-$19.08 M
|
-$11.82 M
|
-$12.90 M
|
-$8.87 M
|
-$9.92 M
|
-$3.35 M
|
| Income Before Tax Ratio |
-1.35
|
-1.06
|
-0.92
|
-0.53
|
-0.56
|
-0.45
|
-0.6
|
-0.53
|
-0.71
|
-0.27
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$44.63 M
|
-$41.06 M
|
-$37.92 M
|
-$23.57 M
|
-$19.08 M
|
-$11.82 M
|
-$12.90 M
|
-$8.87 M
|
-$9.92 M
|
-$3.35 M
|
| Net Income Ratio |
-1.35
|
-1.06
|
-0.92
|
-0.53
|
-0.56
|
-0.45
|
-0.6
|
-0.53
|
-0.71
|
-0.27
|
| EPS |
-0.42 |
-0.39 |
-0.37 |
-0.19 |
-0.22 |
-0.18 |
-0.24 |
-0.17 |
-0.2 |
-0.0998 |
| EPS Diluted |
-0.42 |
-0.39 |
-0.37 |
-0.19 |
-0.22 |
-0.18 |
-0.24 |
-0.17 |
-0.2 |
-0.0998 |
| Weighted Average Shares Out |
$106.43 M
|
$104.85 M
|
$103.27 M
|
$101.70 M
|
$90.62 M
|
$69.46 M
|
$56.40 M
|
$51.18 M
|
$48.64 M
|
$33.52 M
|
| Weighted Average Shares Out Diluted |
$106.43 M
|
$104.85 M
|
$103.27 M
|
$101.70 M
|
$90.62 M
|
$69.46 M
|
$56.40 M
|
$51.18 M
|
$48.64 M
|
$33.52 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
